Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelly Tadger

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Psychogeriatrics|July 16, 2008
Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidoneShelly Tadger, Yehuda Baruch, Yoram Barak
Archives of Gerontology and Geriatrics|August 4, 2010
Quetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: a retrospective chart reviewShelly Tadger, Diana Paleacu, Yoram Barak
International Psychogeriatrics|April 16, 2011
Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot studyYoram Barak, Igor Plopski, Shelly Tadger, et al.
The Israel Journal of Psychiatry and Related Sciences|January 26, 2015
Real-life decision making of Serious Mental Illness patients: Opt-in and opt-out research participationAmira Or, Yehuda Baruch, Shelly Tadger, et al.
Journal of Affective Disorders|August 11, 2012
Asenapine for elderly bipolar manic patientsYehuda Baruch, Shelly Tadger, Igor Plopski, et al.
International Psychogeriatrics|August 29, 2014
Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophreniaShani Pridan, Marnina Swartz, Yehuda Baruch, et al.
Clinical Neuropharmacology|January 13, 2015
Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up studyDiana Paleacu Kertesz, Marnina Vanetik Swartz, Shelly Tadger, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2016
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot StudyAssaf Shelef, Yoram Barak, Uri Berger, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Psychogeriatrics|July 16, 2008
Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidoneShelly Tadger, Yehuda Baruch, Yoram Barak
Archives of Gerontology and Geriatrics|August 4, 2010
Quetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: a retrospective chart reviewShelly Tadger, Diana Paleacu, Yoram Barak
International Psychogeriatrics|April 16, 2011
Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot studyYoram Barak, Igor Plopski, Shelly Tadger, et al.
The Israel Journal of Psychiatry and Related Sciences|January 26, 2015
Real-life decision making of Serious Mental Illness patients: Opt-in and opt-out research participationAmira Or, Yehuda Baruch, Shelly Tadger, et al.
Journal of Affective Disorders|August 11, 2012
Asenapine for elderly bipolar manic patientsYehuda Baruch, Shelly Tadger, Igor Plopski, et al.
International Psychogeriatrics|August 29, 2014
Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophreniaShani Pridan, Marnina Swartz, Yehuda Baruch, et al.
Clinical Neuropharmacology|January 13, 2015
Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up studyDiana Paleacu Kertesz, Marnina Vanetik Swartz, Shelly Tadger, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2016
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot StudyAssaf Shelef, Yoram Barak, Uri Berger, et al.
Pageof 1